Company Filing History:
Years Active: 2025
Title: Michael Cantor: Innovator in Sepsis Treatment
Introduction
Michael Cantor is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of sepsis. His innovative approach has the potential to improve outcomes for patients suffering from this serious condition.
Latest Patents
Michael Cantor holds a patent for the treatment of sepsis with PCSK9 and LDLR modulators. This patent outlines methods for treating subjects with sepsis, SIRS, septic shock, and/or MODS. It also includes methods for identifying individuals at increased risk of developing these conditions, as well as techniques for detecting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) variant nucleic acid molecules and polypeptides.
Career Highlights
Michael Cantor is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to work on groundbreaking medical research. His expertise in the field has positioned him as a valuable asset to the company and the medical community.
Collaborations
He collaborates with talented colleagues, including Julie Horowitz and Luca Andrea Lotta, who contribute to the innovative research environment at Regeneron Pharmaceuticals.
Conclusion
Michael Cantor's work in developing treatments for sepsis showcases his dedication to advancing medical science. His patent and ongoing research efforts highlight the importance of innovation in addressing critical health challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.